Merck
CN
  • Absence-like seizures and their pharmacological profile in tottering-6j mice.

Absence-like seizures and their pharmacological profile in tottering-6j mice.

Biochemical and biophysical research communications (2015-05-24)
Tae Yeon Kim, Takehiro Maki, Ying Zhou, Keita Sakai, Yuri Mizuno, Akiyoshi Ishikawa, Ryo Tanaka, Kimie Niimi, Weidong Li, Norihiro Nagano, Eiki Takahashi
ABSTRACT

We previously showed that recessive ataxic tottering-6j mice carried a base substitution (C-to-A) in the consensus splice acceptor sequence linked to exon 5 of the α1 subunit of the Cav2.1 channel gene (Cacna1a), resulting in the skipping of exon 5 and deletion of part of the S4-S5 linker, S5, and part of the S5-S6 linker in domain I of the α1 subunit of the Cav2.1 channel. However, the electrophysiological and pharmacological consequences of this mutation have not previously been investigated. Upon whole-cell patch recording of the recombinant Cav2.1 channel in heterologous reconstitution expression systems, the mutant-type channel exhibited a lower recovery time after inactivation of Ca(2+) channel current, without any change in peak current density or the current-voltage relationship. Tottering-6j mice exhibited absence-like seizures, characterized by bilateral and synchronous 5-8 Hz spike-and-wave discharges on cortical and hippocampal electroencephalograms, concomitant with sudden immobility and staring. The pharmacological profile of the seizures was similar to that of human absence epilepsy; the seizures were inhibited by ethosuximide and valproic acid, but not by phenytoin. Thus, the tottering-6j mouse is a useful model for studying Cav2.1 channel functions and Cacna1a-related diseases, including absence epilepsy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pyrrolidone hydrotribromide, 97%
Sigma-Aldrich
2-Propylpentanoic acid
Sigma-Aldrich
5,5-Diphenylhydantoin, ≥98%
Sigma-Aldrich
Ethosuximide